VIVEVE MEDICAL, INC.: Nasdaq/NYSE listing notice — Viveve Medical receives Nasdaq deficiency notice for stockholders' equity below $2.5M

VIVEVE MEDICAL, INC.

Reported stockholders' equity of $1,184,000 as of Sept 30, 2022, below Nasdaq's $2,500,000 minimum.
Nasdaq gave company 45 days (until Jan 3, 2023) to submit a plan to regain compliance.
If plan accepted, company has up to 180 days from Nov 18, 2022 to evidence compliance.
Company also previously disclosed non-compliance with minimum bid price rule ($1.00/share) on June 3, 2022.
No assurance of regaining compliance; failure could lead to delisting and hearing rights.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

VIVEVE MEDICAL, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

November 18, 2022, Viveve Medical, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its quarterly report on Form 10-Q for the quarter ended September 30, 2022 filed with the Securities and Exchange Commission (the “Commission”) on November 10, 2022, the Company reported stockholders’ equity of $1,184,000, and, as a result, does not currentl

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001437749-22-028025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.